Matinas Biopharma Holdings, Inc (MTNB) Financials
MTNB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 29.8 million | 6.6 million |
2023-06-30 | 34.0 million | 6.2 million |
2023-03-31 | 38.3 million | 5.6 million |
2022-12-31 | 44.8 million | 8.2 million |
MTNB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.4 million | 1.2 million |
2023-06-30 | -2.4 million | 1.2 million |
2023-03-31 | -4.1 million | 1.3 million |
2022-12-31 | -4.3 million | 1.3 million |
MTNB Net Income
No data available :(
MTNB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 18.2 million | - | 3.7 million |
2023-06-30 | 22.5 million | - | 3.9 million |
2023-03-31 | 24.9 million | - | 4.0 million |
2022-12-31 | 28.8 million | - | 4.1 million |
MTNB Shares Outstanding
MTNB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 16000 | 3.3 million | 2.8 million | - |
2023-06-30 | 202000 | 3.6 million | 2.6 million | - |
2023-03-31 | 202000 | 4.0 million | 2.7 million | - |
2022-12-31 | 41601 | 3.9 million | 2.7 million | - |
MTNB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 238000 |
2023-06-30 | - | 234000 |
2023-03-31 | 1.1 million | 229000 |
2022-12-31 | 1.1 million | 3.5 million |
MTNB
Price: $0.17
52 week price:
Earnings Per Share: -0.11 USD
P/E Ratio: -2.08
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 237100
Market Capitalization: 51.0 million